CLSN

Celsion Corporation News Headlines

$2.54
*  
0.085
3.24%
Get CLSN Alerts
*Delayed - data as of Oct. 22, 2014  -  Find a broker to begin trading CLSN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Celsion To Present At Rodman & Renshaw Conference;Webcast At 10:50 AM ET
9/9/2014 9:50:00 AM - RTT News


Celsion: Data On ThermoDox Published In International Journal Of Hyperthermia
9/4/2014 9:19:00 AM - RTT News


Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies
8/12/2014 10:43:00 AM - Seeking Alpha


Celsion Showing Small Signs Of Life After Tanking 95%
7/30/2014 2:11:00 PM - Seeking Alpha


Celsion Reports Updated Survival Data In ThermoDox Study Of Liver Cancer
7/28/2014 8:33:00 AM - RTT News


Celsion (CLSN) in Focus: Stock Adds 5.3% in Session - Tale of the Tape
7/25/2014 8:51:00 AM - Zacks.com


Celsion's EGEN Acquisition Brings Immunotherapy And RNA Therapeutics To Its Cancer Platform
7/22/2014 1:29:00 PM - Seeking Alpha


Celsion (CLSN) Enters Overbought Territory - Tale of the Tape
6/17/2014 11:21:54 AM - Zacks.com


Sector Update: Healthcare Shares Mixed Pre-Market; Isis Earns Milestone Payment
6/10/2014 8:40:33 AM - MT Newswires


Sector Update: Healthcare
6/10/2014 8:39:56 AM - MT Newswires


Update on Celsion's ThermoDox - Analyst Blog
5/23/2014 5:00:00 PM - Zacks.com


Threshold Pharmaceuticals Presents A Robust Risk/Reward As A Speculative Small-Cap Cancer Investment
5/9/2014 12:58:00 PM - Seeking Alpha


Celsion (CLSN) Enters Oversold Territory - Tale of the Tape
4/9/2014 8:53:01 AM - Zacks.com


Speculating On Celsion: Low Valuation With Near-Term Catalysts
3/3/2014 10:51:00 AM - Seeking Alpha


Celsion's OPTIMA Study: What You Need To Know
2/26/2014 11:01:00 AM - Seeking Alpha


Celsion's Newest Cancer Treatment Adds To Upside
2/13/2014 4:37:00 PM - Seeking Alpha


Data on Celsion's ThermoDox - Analyst Blog
1/28/2014 6:40:01 PM - Zacks.com


Celsion Provides Encouraging Post-Hoc O/S Data From HEAT Trial
1/27/2014 11:05:00 AM - Seeking Alpha


The Anatomy Of A Seemingly Random Celsion Upgrade
1/13/2014 1:03:00 PM - Seeking Alpha


3 Things I Want From Celsion In 2014
12/31/2013 12:13:00 PM - Seeking Alpha


Celsion Shows Possible Enormous ThermoDox Potential In Phase I DIGNITY Results
12/13/2013 10:46:00 AM - Seeking Alpha


Celsion's Targeted RF Therapy Represents Tremendous Medical Opportunity For Cancer
11/5/2013 9:47:00 AM - Seeking Alpha


2013 Biotech Watchlist Update: Companies Climb And Crumble On Catalysts
11/1/2013 11:48:00 AM - Seeking Alpha


Celsion Continues Publishing Meaningless Post-Hoc Data Mined Results
10/24/2013 1:02:00 PM - Seeking Alpha


Is The HEAT On For Celsion?
10/24/2013 10:54:00 AM - Seeking Alpha